March 2, 2017
Via: Kaiser Health NewsHigh-profile advocacy groups for patients with cancer, Alzheimer’s, HIV and other diseases almost always accept funding from pharmaceutical firms, and many fail to report any contributions, new research shows. At least 83 percent of the nation’s 104 largest patient advocacy […]
March 2, 2023
February 28, 2023